GBC sets MS Industrie buy rating with EUR 2.5 price target
Reuters2026/08/27 09:00- GBC reiterated a Buy rating on MS Industrie, keeping its EUR 2.5 price target through Dec. 31, 2027.
- H1 2026 revenue rose 0.7% to EUR 75.76 million; EBITDA improved to EUR 5.17 million from EUR 4.23 million.
- Net profit turned positive at EUR 0.11 million from a EUR 1.38 million loss, helped by lower start-up costs and depreciation.
- Guidance stayed unchanged for 2026 revenue of EUR 155 million; management expects stronger H2 on higher call-offs, EUR 82 million backlog.
- DCF-based valuation kept unchanged; a higher risk-free rate was offset by roll-over effects, leaving the target intact.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
